ImmunoPrecise (IPA) - Tingkat bathi reged

Lambang korporat lan logo ImmunoPrecise Antibodies (IPA)

The development of ImmunoPrecise Antibodies (IPA) has been driven by the implementation of autonomous microfluidic systems for B-cell screening. Gross margin after deducting cost of sales demonstrates current dynamics, where the 47.20 metric confirms the current level of efficiency. Looking ahead, success depends on the commercial return of the AI platform and the resilience of biopharma orders to interest rate fluctuations, which will determine the long-term valuation of the business.

Rentabilitas reged ImmunoPrecise Antibodies (IPA): kanggo periode 04.07.2022 - 04.09.2025

Rincian metrik keuangan lan pasar ImmunoPrecise Antibodies (IPA)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:immunoprecise.com, IPA
Barang unggulan ImmunoPrecise

The B2B model of ImmunoPrecise Antibodies (IPA), based on providing biotechnological platforms to pharma behemoths, determines the company's direct cost structure. By analyzing the gross margin, an investor can see the portion of revenue net of production costs, which reflects the efficiency of resource management. The trend in this gross margin metric allows for an assessment of the balance between the high pricing power of intellectual services and capital expenditures in product development.

Pesaing utama

Tingkat bathi miturut bathi reged Tempus AI Inc|QGEN (Qiagen NV) - Margin reged|Tingkat bathi miturut bathi reged Ionis Pharma (IONS)|Rentabilitas reged Repligen Corp (RGEN)|RNA - Margin bathi reged|crisprtx.com - Tingkat bathi miturut bathi reged|Tingkat bathi reged WGS|RARE - Rentabilitas reged|Beam Tx (BEAM) - Tingkat bathi miturut bathi reged|SRPT (Sarepta Therapeutics Inc) - Tingkat bathi miturut bathi reged|TWST: Rasio bathi reged|TXG (10xgenomics.com) - Margin reged|NTLA (Intellia Therapeutics, Inc.) - Rasio bathi reged|Rentabilitas reged Stoke Corp (STOK)|Rentabilitas dodolan miturut bathi reged BioLife|Margin reged WVE (Wave Life Sciences Ltd)|MAZE: Rentabilitas dodolan reged|Sionna Therapeutics, Inc. - Margin reged|Tingkat bathi reged PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Tingkat bathi miturut bathi reged|QURE - Rentabilitas dodolan miturut bathi reged|MGTX (MeiraGTx Corp) - Margin reged|Margin bathi reged REGENXBIO Inc. RGNX|Rentabilitas reged Solid Biosciences (SLDB)|Ocugen Corp - Rentabilitas dodolan reged|Rentabilitas reged Pacific Biosciences PACB|Rasio bathi reged BNTC (Benitec)|Design Corp - Margin reged|Rocket Pharmaceuticals - Rasio bathi reged|Rentabilitas dodolan reged 4D Molecular Therapeutics, Inc.|Margin bathi reged Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Margin reged|Margin bathi reged Editas EDIT|Margin reged SLN|ProQR Therapeutics - Rentabilitas dodolan reged|Margin reged CDXS (Codexis, Inc.)|SGMO: Rentabilitas dodolan reged|Nautilus Biotechnology - Margin reged|Tingkat bathi reged MGX (Metagenomi, Inc)|DTIL: Margin reged|GBIO: Rasio bathi reged|Rentabilitas reged Boundless Bio Inc.|Tingkat bathi miturut bathi reged Exicure (XCUR)|Margin reged IMNN|PHIO (Phio Pharmaceuticals Corp.) - Tingkat bathi reged|Mustang Bio, Inc. - Tingkat bathi miturut bathi reged|RNAZ - Tingkat bathi miturut bathi reged|BNGO: Tingkat bathi miturut bathi reged|APDN (Applied DNA Sciences Inc) - Rentabilitas dodolan reged|BLUE (Bluebird Bio) - Tingkat bathi miturut bathi reged|Tingkat bathi adhedhasar bathi reged OMGA (Omega)|Rentabilitas reged Singular Genomics Systems|Margin bathi reged regulusrx.com RGLS|Rentabilitas reged Syros Pharmaceuticals Inc. (SYRS)|Rentabilitas dodolan miturut bathi reged Codex DNA|Rentabilitas reged TRACON TCON|Unity Biotechnology, Inc - Rentabilitas reged